Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five ...